-
1
-
-
0030976173
-
Cancer undefeated
-
J.C. Bailar, and H.L. Gornik Cancer undefeated N Engl J Med 336 22 1997 1569 1574
-
(1997)
N Engl J Med
, vol.336
, Issue.22
, pp. 1569-1574
-
-
Bailar, J.C.1
Gornik, H.L.2
-
2
-
-
0033617532
-
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
-
G. Bergers, K. Javaherian, K.M. Lo, J. Folkman, and D. Hanahan Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 1999 808 812
-
(1999)
Science
, vol.284
, pp. 808-812
-
-
Bergers, G.1
Javaherian, K.2
Lo, K.M.3
Folkman, J.4
Hanahan, D.5
-
3
-
-
0029944122
-
Angiostatin induces and sustains dormancy of human primary tumors in mice
-
M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat Med 2 1996 689 692
-
(1996)
Nat Med
, vol.2
, pp. 689-692
-
-
O'Reilly, M.S.1
Holmgren, L.2
Chen, C.3
Folkman, J.4
-
4
-
-
0034244239
-
Prolonged stable disease effects survival in patients with solid gastric tumor: Analysis of phase II studies of doxifluridine
-
Y. Takahashi, M. Mai, T. Taguchi, I. Urushizaki, and K. Nishioka Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine Int J Oncol 17 2000 285 289
-
(2000)
Int J Oncol
, vol.17
, pp. 285-289
-
-
Takahashi, Y.1
Mai, M.2
Taguchi, T.3
Urushizaki, I.4
Nishioka, K.5
-
5
-
-
0033577247
-
Measuring response in solid tumors: Unidimensional versus bidimensional measurement
-
K. James, E. Eisenhauer, M. Christian, M. Terenziani, D. Vena, and A. Muldal Measuring response in solid tumors: unidimensional versus bidimensional measurement J Natl Cancer Inst 91 6 1999 523 528
-
(1999)
J Natl Cancer Inst
, vol.91
, Issue.6
, pp. 523-528
-
-
James, K.1
Eisenhauer, E.2
Christian, M.3
Terenziani, M.4
Vena, D.5
Muldal, A.6
-
6
-
-
0035154256
-
Clinical trial designs for cytostatic agents: Are new approaches needed?
-
E.L. Korn, S.G. Arbuck, J.M. Pluda, R. Simon, R.S. Kaplan, and M.C. Christian Clinical trial designs for cytostatic agents: are new approaches needed? J Clin Oncol 19 1 2001 265 272
-
(2001)
J Clin Oncol
, vol.19
, Issue.1
, pp. 265-272
-
-
Korn, E.L.1
Arbuck, S.G.2
Pluda, J.M.3
Simon, R.4
Kaplan, R.S.5
Christian, M.C.6
-
7
-
-
0003286786
-
Surrogate markers for the assessment of biological activity of the VEGF-receptor inhibitor PTK787/ZK 222584 (PTK/ZK) in two clinical phase I trials
-
J. Drevs, C.I. Schmidt-Gersbach, K. Mross, M. Medinger, M. Mueller, and W. Steward Surrogate markers for the assessment of biological activity of the VEGF-receptor inhibitor PTK787/ZK 222584 (PTK/ZK) in two clinical phase I trials Proc Am Soc Clin Oncol 21 2002 a337
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Drevs, J.1
Schmidt-Gersbach, C.I.2
Mross, K.3
Medinger, M.4
Mueller, M.5
Steward, W.6
-
8
-
-
0034092011
-
Tumor angiogenesis: Past, present and the near future
-
R.S. Kerbel Tumor angiogenesis: past, present and the near future Carcinogenesis 21 2000 505 515
-
(2000)
Carcinogenesis
, vol.21
, pp. 505-515
-
-
Kerbel, R.S.1
-
10
-
-
0037440123
-
Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors
-
J.P. Thomas, R.Z. Arzoomanian, D. Alberti, R. Marnocha, F. Lee, and A. Friedl Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 21 2 2003 223 231
-
(2003)
J Clin Oncol
, vol.21
, Issue.2
, pp. 223-231
-
-
Thomas, J.P.1
Arzoomanian, R.Z.2
Alberti, D.3
Marnocha, R.4
Lee, F.5
Friedl, A.6
-
11
-
-
0028470454
-
Barriers to drug delivery in solid tumors
-
R.K. Jain Barriers to drug delivery in solid tumors Sci Educ Bull 271 1994 58 65
-
(1994)
Sci Educ Bull
, vol.271
, pp. 58-65
-
-
Jain, R.K.1
-
12
-
-
0034047595
-
Applications of magnetic resonance in model systems. Cancer Therapeutics
-
J.L. Evelhoch, R.J. Gillies, G.S. Karczmar, J.A. Koutcher, R.J. Maxwell, and O. Nalcioglu Applications of magnetic resonance in model systems. Cancer Therapeutics Neoplasia 2 2000 152 165
-
(2000)
Neoplasia
, vol.2
, pp. 152-165
-
-
Evelhoch, J.L.1
Gillies, R.J.2
Karczmar, G.S.3
Koutcher, J.A.4
Maxwell, R.J.5
Nalcioglu, O.6
-
13
-
-
0034765047
-
Dynamic contrast-enhanced magnetic resonance imaging in oncology
-
M.V. Knopp, F. Giesel, H. Marcos, H. von Tengg-Kobligk, and P. Choyke Dynamic contrast-enhanced magnetic resonance imaging in oncology Top Magn Reson Imaging 12 4 2001 301 308
-
(2001)
Top Magn Reson Imaging
, vol.12
, Issue.4
, pp. 301-308
-
-
Knopp, M.V.1
Giesel, F.2
Marcos, H.3
Von Tengg-Kobligk, H.4
Choyke, P.5
-
14
-
-
0036136820
-
Translating molecular imaging
-
B.J. Hillman, and H.L. Neiman Translating molecular imaging Radiology 222 2002 19 24
-
(2002)
Radiology
, vol.222
, pp. 19-24
-
-
Hillman, B.J.1
Neiman, H.L.2
-
15
-
-
0035884219
-
Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results
-
R.S. Kerbel Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results J Clin Oncol 19 18s 2001 45s 51s
-
(2001)
J Clin Oncol
, vol.19
, Issue.18
-
-
Kerbel, R.S.1
-
16
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
P. Carmeliet, and R. Jain Angiogenesis in cancer and other diseases Nature 407(6801) 2000 249 257
-
(2000)
Nature
, vol.407
, Issue.6801
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.2
-
17
-
-
0036842215
-
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
-
H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 21 2002 4368 4380
-
(2002)
J Clin Oncol
, vol.20
, Issue.21
, pp. 4368-4380
-
-
Dvorak, H.F.1
-
18
-
-
0031443206
-
A cancer therapy resistant to resistance
-
R.S. Kerbel A cancer therapy resistant to resistance Nature 390 1997 335 336
-
(1997)
Nature
, vol.390
, pp. 335-336
-
-
Kerbel, R.S.1
-
19
-
-
0037093249
-
Influence of unrecognized molecular heterogeneity on randomized clinical trials
-
R.A. Betensky, D.N. Louis, and J.G. Cairncross Influence of unrecognized molecular heterogeneity on randomized clinical trials J Clin Oncol 20 2002 2495 2499
-
(2002)
J Clin Oncol
, vol.20
, pp. 2495-2499
-
-
Betensky, R.A.1
Louis, D.N.2
Cairncross, J.G.3
-
20
-
-
0035100888
-
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
-
Biomarkers Definitions Working Group Bethesda
-
Biomarkers Definitions Working Group Bethesda Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 3 2001 89 95
-
(2001)
Clin Pharmacol Ther
, vol.69
, Issue.3
, pp. 89-95
-
-
-
21
-
-
0031886171
-
Tumors characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights
-
M.Y. Su, A. Muhler, X. Lao, and O. Nalcioglu Tumors characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights Magn Reson Med 39 2 1998 259 269
-
(1998)
Magn Reson Med
, vol.39
, Issue.2
, pp. 259-269
-
-
Su, M.Y.1
Muhler, A.2
Lao, X.3
Nalcioglu, O.4
-
22
-
-
0032828135
-
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: Standardized quantities and symbols
-
P.S. Tofts, G. Brix, D.L. Buckley, J.L. Evelhoch, E. Henderson, and M.V. Knopp Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols J Magn Reson Imaging 10 3 1999 223 232
-
(1999)
J Magn Reson Imaging
, vol.10
, Issue.3
, pp. 223-232
-
-
Tofts, P.S.1
Brix, G.2
Buckley, D.L.3
Evelhoch, J.L.4
Henderson, E.5
Knopp, M.V.6
-
23
-
-
0029787388
-
Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
-
L.D. Buadu, J. Murakami, S. Murayama, N. Hashiguchi, S. Sakai, and K. Masuda Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis Radiology 200 3 1996 639 649
-
(1996)
Radiology
, vol.200
, Issue.3
, pp. 639-649
-
-
Buadu, L.D.1
Murakami, J.2
Murayama, S.3
Hashiguchi, N.4
Sakai, S.5
Masuda, K.6
-
24
-
-
0031723118
-
Angiogenic activity of cervical carcinoma: Assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome
-
H. Hawighorst, P.G. Knapstein, M.V. Knopp, and W. Weikel Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome Clin Cancer Res 4 10 1998 2305 2312
-
(1998)
Clin Cancer Res
, vol.4
, Issue.10
, pp. 2305-2312
-
-
Hawighorst, H.1
Knapstein, P.G.2
Knopp, M.V.3
Weikel, W.4
-
25
-
-
0031912025
-
Prediction of tumor control in patients with cervical cancer: Analysis of combined volume and dynamic enhancement pattern by MR imaging
-
N.A. Mayr, W.T. Yuh, J. Zheng, J.C. Ehrhardt, V.A. Magnotta, and J.I. Sorosky Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging Am J Roentgenol 170 1 1998 177 182
-
(1998)
Am J Roentgenol
, vol.170
, Issue.1
, pp. 177-182
-
-
Mayr, N.A.1
Yuh, W.T.2
Zheng, J.3
Ehrhardt, J.C.4
Magnotta, V.A.5
Sorosky, J.I.6
-
26
-
-
0030876719
-
Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions
-
P.C. Stomper, J.S. Winston, S. Herman, D.L. Klippenstein, M.A. Arredondo, and L.E. Blumenson Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions Breast Cancer Res Treat 45 1 1997 39 46
-
(1997)
Breast Cancer Res Treat
, vol.45
, Issue.1
, pp. 39-46
-
-
Stomper, P.C.1
Winston, J.S.2
Herman, S.3
Klippenstein, D.L.4
Arredondo, M.A.5
Blumenson, L.E.6
-
27
-
-
0030657917
-
Dynamic echo-planar imaging of the breast: Experience in diagnosing breast carcinoma and correlation with tumor angiogenesis
-
C.A. Hulka, W.B. Edmister, B.L. Smith, L. Tan, D.C. Sgroi, and T. Campbell Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis Radiology 205 3 1997 837 842
-
(1997)
Radiology
, vol.205
, Issue.3
, pp. 837-842
-
-
Hulka, C.A.1
Edmister, W.B.2
Smith, B.L.3
Tan, L.4
Sgroi, D.C.5
Campbell, T.6
-
28
-
-
0032863707
-
Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma
-
W.E. Reddick, J.S. Taylor, and B.D. Fletcher Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma J Magn Reson Imaging 10 3 1999 277 285
-
(1999)
J Magn Reson Imaging
, vol.10
, Issue.3
, pp. 277-285
-
-
Reddick, W.E.1
Taylor, J.S.2
Fletcher, B.D.3
-
29
-
-
0031946469
-
Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
-
C.D. Pham, T.P. Roberts, N. van Bruggen, O. Melnyk, J. Mann, and N. Ferrara Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor Cancer Invest 16 4 1998 225 230
-
(1998)
Cancer Invest
, vol.16
, Issue.4
, pp. 225-230
-
-
Pham, C.D.1
Roberts, T.P.2
Van Bruggen, N.3
Melnyk, O.4
Mann, J.5
Ferrara, N.6
-
31
-
-
0032968340
-
Improved delineation of human brain tumors on MR images using a long-circulating superparamagnetic iron oxide agent
-
W.S. Enochs, G. Harsh, F. Hochberg, and R. Weissleder Improved delineation of human brain tumors on MR images using a long-circulating superparamagnetic iron oxide agent J Magn Reson Imaging 9 1999 228 232
-
(1999)
J Magn Reson Imaging
, vol.9
, pp. 228-232
-
-
Enochs, W.S.1
Harsh, G.2
Hochberg, F.3
Weissleder, R.4
-
32
-
-
0037612351
-
New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer
-
J. Rydland, A. Bjornerud, O.A. Haugen, G. Torheim, C. Torres, and K.A. Kvistad New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer Acta Radiol 44 3 2003 275 283
-
(2003)
Acta Radiol
, vol.44
, Issue.3
, pp. 275-283
-
-
Rydland, J.1
Bjornerud, A.2
Haugen, O.A.3
Torheim, G.4
Torres, C.5
Kvistad, K.A.6
-
33
-
-
0347615101
-
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases
-
B. Morgan, A.L. Thomas, J. Drevs, J. Hennig, M. Buchert, and A. Jivan Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases J Clin Oncol 21 2003 3955 3964
-
(2003)
J Clin Oncol
, vol.21
, pp. 3955-3964
-
-
Morgan, B.1
Thomas, A.L.2
Drevs, J.3
Hennig, J.4
Buchert, M.5
Jivan, A.6
-
34
-
-
0029864434
-
Myocardial perfusion modeling using MRI
-
H.B. Larsson, T. Fritz-Hansen, E. Rostrup, L. Sondergaard, P. Ring, and O. Henriksen Myocardial perfusion modeling using MRI Magn Reson Med 35 5 1996 716 726
-
(1996)
Magn Reson Med
, vol.35
, Issue.5
, pp. 716-726
-
-
Larsson, H.B.1
Fritz-Hansen, T.2
Rostrup, E.3
Sondergaard, L.4
Ring, P.5
Henriksen, O.6
-
35
-
-
0042519916
-
A phase I trial of single-agent PTK 787/ZK 222584 (PTK/ZK), an oral VEGFR tyrosine kinase inhibitor, in patients with recurrent glioblastoma multiforme [abstract]
-
W.K.A. Yung, H. Friedman, C. Conrad, D. Reardon, J. Provenzale, and E. Jackson A phase I trial of single-agent PTK 787/ZK 222584 (PTK/ZK), an oral VEGFR tyrosine kinase inhibitor, in patients with recurrent glioblastoma multiforme [abstract] Proc Am Soc Clin Oncol 22 2003 99
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 99
-
-
Yung, W.K.A.1
Friedman, H.2
Conrad, C.3
Reardon, D.4
Provenzale, J.5
Jackson, E.6
-
36
-
-
0642281450
-
Antiangiogenic therapy: More promise and, yet again, more questions
-
L.M. Ellis Antiangiogenic therapy: more promise and, yet again, more questions J Clin Oncol 21 21 2003 3897 3899
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 3897-3899
-
-
Ellis, L.M.1
-
37
-
-
0034255151
-
Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases
-
C.J. Bruns, W. Liu, D.W. Davis, R.M. Shaheen, D.J. McConkey, and M.R. Wilson Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases Cancer 89 2000 488 499
-
(2000)
Cancer
, vol.89
, pp. 488-499
-
-
Bruns, C.J.1
Liu, W.2
Davis, D.W.3
Shaheen, R.M.4
McConkey, D.J.5
Wilson, M.R.6
-
38
-
-
0032952010
-
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
-
L.E. Benjamin, D. Golijanin, A. Itin, D. Pode, and E. Keshet Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J Clin Invest 103 2 1999 159 165
-
(1999)
J Clin Invest
, vol.103
, Issue.2
, pp. 159-165
-
-
Benjamin, L.E.1
Golijanin, D.2
Itin, A.3
Pode, D.4
Keshet, E.5
-
39
-
-
0033609922
-
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
-
H. He, V.J. Venema, X. Gu, R.C. Venema, M.B. Marrero, and R.B. Caldwell Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J Biol Chem 274 1999 25130 25135
-
(1999)
J Biol Chem
, vol.274
, pp. 25130-25135
-
-
He, H.1
Venema, V.J.2
Gu, X.3
Venema, R.C.4
Marrero, M.B.5
Caldwell, R.B.6
-
40
-
-
0042386691
-
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging
-
S.M. Galbraith, R.J. Maxwell, M.A. Lodge, G.M. Tozer, J. Wilson, and N.J. Taylor Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging J Clin Oncol 21 15 2003 2831 2842
-
(2003)
J Clin Oncol
, vol.21
, Issue.15
, pp. 2831-2842
-
-
Galbraith, S.M.1
Maxwell, R.J.2
Lodge, M.A.3
Tozer, G.M.4
Wilson, J.5
Taylor, N.J.6
-
41
-
-
0037106501
-
Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging
-
S.M. Galbraith, G.J.S. Rustin, M. Lodge, N.J. Taylor, J.J. Stirling, and M. Jameson Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging J Clin Oncol 20 18 2002 3826 3840
-
(2002)
J Clin Oncol
, vol.20
, Issue.18
, pp. 3826-3840
-
-
Galbraith, S.M.1
Rustin, G.J.S.2
Lodge, M.3
Taylor, N.J.4
Stirling, J.J.5
Jameson, M.6
-
42
-
-
0009347961
-
Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of efficacy in a phase I trial of a VEGF receptor tyrosine kinase inhibitor
-
B. Morgan, H. Ball, M. Buchert, G. Cherryman, J. Drevs, and M. Dugan Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of efficacy in a phase I trial of a VEGF receptor tyrosine kinase inhibitor Proc Am Assoc Cancer Res 42 2001 587
-
(2001)
Proc Am Assoc Cancer Res
, vol.42
, pp. 587
-
-
Morgan, B.1
Ball, H.2
Buchert, M.3
Cherryman, G.4
Drevs, J.5
Dugan, M.6
-
43
-
-
0035205433
-
Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
-
M.L. George, A.S. Dzik-Jurasz, A.R. Padhani, G. Brown, D.M. Tait, and S.A. Eccles Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer Br J Surg 88 12 2001 1628 1636
-
(2001)
Br J Surg
, vol.88
, Issue.12
, pp. 1628-1636
-
-
George, M.L.1
Dzik-Jurasz, A.S.2
Padhani, A.R.3
Brown, G.4
Tait, D.M.5
Eccles, S.A.6
-
44
-
-
5044222917
-
Conventional cytotoxic chemotherapy agents do not have acute antivascular effects, as measured by dynamic contrast enhanced MRI (DCE-MRI) [abstract]
-
K.J. Lankester, N.J. Taylor, J.J. Stirling, J. Boxall, M.O. Leach, and A.R. Padhani Conventional cytotoxic chemotherapy agents do not have acute antivascular effects, as measured by dynamic contrast enhanced MRI (DCE-MRI) [abstract] Proc Am Soc Clin Oncol 22 147 2003 a588
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, Issue.147
-
-
Lankester, K.J.1
Taylor, N.J.2
Stirling, J.J.3
Boxall, J.4
Leach, M.O.5
Padhani, A.R.6
-
45
-
-
2942602368
-
Response to anticancer treatment with docetaxel administered every 3 weeks and weekly is associated with functional assessment of changes in tumoral blood flow/perfusion
-
W. Wolfe, C.A. Presant, V. Waluch, and B.J. Le Berthon Response to anticancer treatment with docetaxel administered every 3 weeks and weekly is associated with functional assessment of changes in tumoral blood flow/perfusion Proc Am Assoc Cancer Res 44 2003 5343
-
(2003)
Proc Am Assoc Cancer Res
, vol.44
, pp. 5343
-
-
Wolfe, W.1
Presant, C.A.2
Waluch, V.3
Le Berthon, B.J.4
-
47
-
-
0035866818
-
Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma
-
A.F. DeVries, J. Griebel, C. Kremser, W. Judmaier, T. Gneiting, and A. Kreczy Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma Cancer Res 61 2001 2513 2516
-
(2001)
Cancer Res
, vol.61
, pp. 2513-2516
-
-
Devries, A.F.1
Griebel, J.2
Kremser, C.3
Judmaier, W.4
Gneiting, T.5
Kreczy, A.6
-
48
-
-
0042844535
-
Quantification of blood flow in brain tumors: Comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging
-
C. Warmuth, M. Günther, and C. Zimmer Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging Radiology 228 2003 523 532
-
(2003)
Radiology
, vol.228
, pp. 523-532
-
-
Warmuth, C.1
Günther, M.2
Zimmer, C.3
-
49
-
-
0034914228
-
State of the art: Technologic advances in abdominal MR imaging
-
M.T. Keogan, and R.R. Edelman State of the art: technologic advances in abdominal MR imaging Radiology 220 2001 310 320
-
(2001)
Radiology
, vol.220
, pp. 310-320
-
-
Keogan, M.T.1
Edelman, R.R.2
-
50
-
-
0034161989
-
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
-
A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K.H. Plate, and H.G. Augustin Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies Cancer Res 60 2000 1388 1393
-
(2000)
Cancer Res
, vol.60
, pp. 1388-1393
-
-
Eberhard, A.1
Kahlert, S.2
Goede, V.3
Hemmerlein, B.4
Plate, K.H.5
Augustin, H.G.6
-
51
-
-
0038376001
-
Imaging angiogenesis: From microscope to clinic
-
D.M. McDonald, and P.L. Choyke Imaging angiogenesis: from microscope to clinic Nat Med 9 6 2003 713 725
-
(2003)
Nat Med
, vol.9
, Issue.6
, pp. 713-725
-
-
McDonald, D.M.1
Choyke, P.L.2
-
52
-
-
0032900885
-
Regional blood flow, capillary permeability, and compartmental volumes: Measurement with dynamic CTâ€"initial experience
-
G. Brix, M.L. Bahner, U. Hoffmann, A. Horvath, and W. Schreiber Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CTâ€"initial experience Radiology 210 1 1999 269 276
-
(1999)
Radiology
, vol.210
, Issue.1
, pp. 269-276
-
-
Brix, G.1
Bahner, M.L.2
Hoffmann, U.3
Horvath, A.4
Schreiber, W.5
-
53
-
-
0032865983
-
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review
-
K.A. Miles Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review Eur J Radiol 30 1999 198 205
-
(1999)
Eur J Radiol
, vol.30
, pp. 198-205
-
-
Miles, K.A.1
-
54
-
-
0036337092
-
Dynamic contrast-enhanced functional imaging with multi-slice CT
-
P. Dawson Dynamic contrast-enhanced functional imaging with multi-slice CT Acad Radiol 9 Suppl 2 2002 S368 S370
-
(2002)
Acad Radiol
, vol.9
, Issue.2
-
-
Dawson, P.1
-
55
-
-
0001556502
-
Functional and metabolic imaging
-
V.T. DeVita S. Hellman S.A. Rosenberg 6th edition Lippincott Williams & Wilkins Philadelphia
-
M.G. Pomper Functional and metabolic imaging V.T. DeVita S. Hellman S.A. Rosenberg Cancer: principles & practice of oncology 6th edition 2001 Lippincott Williams & Wilkins Philadelphia 679 689
-
(2001)
Cancer: Principles & Practice of Oncology
, pp. 679-689
-
-
Pomper, M.G.1
-
57
-
-
0035810148
-
Brief report: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
-
H. Joensuu, P.J. Roberts, M. Sarlomo-Rikala, L.C. Andersson, and P. Tervahartiala Brief report: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 14 2001 1052 1056
-
(2001)
N Engl J Med
, vol.344
, Issue.14
, pp. 1052-1056
-
-
Joensuu, H.1
Roberts, P.J.2
Sarlomo-Rikala, M.3
Andersson, L.C.4
Tervahartiala, P.5
-
58
-
-
0036099568
-
Clinical measurement of blood flow in tumours using positron emission tomography: A review
-
H. Anderson, and P. Price Clinical measurement of blood flow in tumours using positron emission tomography: a review Nucl Med Comm 23 2 2002 131 138
-
(2002)
Nucl Med Comm
, vol.23
, Issue.2
, pp. 131-138
-
-
Anderson, H.1
Price, P.2
-
59
-
-
0042887593
-
Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate
-
H.L. Anderson, J.T. Yap, M.P. Miller, A. Robbins, T. Jones, and P.M. Price Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate J Clin Oncol 21 15 2003 2823 2830
-
(2003)
J Clin Oncol
, vol.21
, Issue.15
, pp. 2823-2830
-
-
Anderson, H.L.1
Yap, J.T.2
Miller, M.P.3
Robbins, A.4
Jones, T.5
Price, P.M.6
-
60
-
-
0037106384
-
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin
-
R.S. Herbst, N.A. Mullani, D.W. Davis, K.R. Hess, D.J. McConkey, and C. Charnsangavej Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin J Clin Oncol 20 18 2002 3804 3814
-
(2002)
J Clin Oncol
, vol.20
, Issue.18
, pp. 3804-3814
-
-
Herbst, R.S.1
Mullani, N.A.2
Davis, D.W.3
Hess, K.R.4
McConkey, D.J.5
Charnsangavej, C.6
-
61
-
-
0034282515
-
Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model
-
J. Drevs, I. Hofmann, H. Hugenschmidt, C. Wittig, H. Madjar, and M. Müller Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model Cancer Res 60 2000 4819 4824
-
(2000)
Cancer Res
, vol.60
, pp. 4819-4824
-
-
Drevs, J.1
Hofmann, I.2
Hugenschmidt, H.3
Wittig, C.4
Madjar, H.5
Müller, M.6
-
62
-
-
0036100042
-
Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas
-
N. Lassau, S. Koscielny, M.F. Avril, A. Margulis, P. Duvillard, and T. De Baere Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas Am J Roentgenol 178 6 2002 1547 1551
-
(2002)
Am J Roentgenol
, vol.178
, Issue.6
, pp. 1547-1551
-
-
Lassau, N.1
Koscielny, S.2
Avril, M.F.3
Margulis, A.4
Duvillard, P.5
De Baere, T.6
-
63
-
-
0035154352
-
Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo
-
N. Lassau, S. Koscielny, P. Opolon, T. De Baere, P. Peronneau, and J. Leclere Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo Invest Radiol 36 2001 50 55
-
(2001)
Invest Radiol
, vol.36
, pp. 50-55
-
-
Lassau, N.1
Koscielny, S.2
Opolon, P.3
De Baere, T.4
Peronneau, P.5
Leclere, J.6
-
64
-
-
0031827027
-
Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US: Early experience
-
S. Huber, T. Helbich, J. Kettenbach, W. Dock, I. Zuna, and S. Delorme Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US: early experience Radiology 208 1998 485 489
-
(1998)
Radiology
, vol.208
, pp. 485-489
-
-
Huber, S.1
Helbich, T.2
Kettenbach, J.3
Dock, W.4
Zuna, I.5
Delorme, S.6
-
65
-
-
0037106374
-
Mechanisms and future directions for angiogenesis-based cancer therapies
-
F.A. Scappaticci Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 18 2002 3906 3927
-
(2002)
J Clin Oncol
, vol.20
, Issue.18
, pp. 3906-3927
-
-
Scappaticci, F.A.1
-
66
-
-
0033737924
-
Measuring tumor blood flow with H(2)(15)O: Practical considerations
-
S.L. Bacharach, S.K. Libutti, and J.A. Carrasquillo Measuring tumor blood flow with H(2)(15)O: Practical considerations Nucl Med Biol 27 2000 671 676
-
(2000)
Nucl Med Biol
, vol.27
, pp. 671-676
-
-
Bacharach, S.L.1
Libutti, S.K.2
Carrasquillo, J.A.3
-
67
-
-
0036191012
-
Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI
-
D.L. Buckley Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI Magn Reson Med 47 3 2002 601 606
-
(2002)
Magn Reson Med
, vol.47
, Issue.3
, pp. 601-606
-
-
Buckley, D.L.1
-
68
-
-
5044232696
-
Biomarkers for the assessment of pharmacological activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): Comparison of per clinical data with results in phase I studies [abstract]
-
Boston, MA. November 19
-
Lee L, McSheehy P, Morgan B, Laird G, Allegrini P, Cozens R, et al. Biomarkers for the assessment of pharmacological activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): comparison of per clinical data with results in phase I studies [abstract]. Presented at the 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA. November 19, 2003
-
(2003)
2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
-
-
Lee, L.1
McSheehy, P.2
Morgan, B.3
Laird, G.4
Allegrini, P.5
Cozens, R.6
-
69
-
-
0036198715
-
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis
-
S.M. Galbraith, M.A. Lodge, N.J. Taylor, G.J. Rustin, S. Bentzen, and J.J. Stirling Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis NMR Biomed 15 2 2002 132 142
-
(2002)
NMR Biomed
, vol.15
, Issue.2
, pp. 132-142
-
-
Galbraith, S.M.1
Lodge, M.A.2
Taylor, N.J.3
Rustin, G.J.4
Bentzen, S.5
Stirling, J.J.6
-
70
-
-
0032893756
-
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells
-
E.O. Aboagye, and Z.M. Bhujwalla Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res 59 1 1999 80 84
-
(1999)
Cancer Res
, vol.59
, Issue.1
, pp. 80-84
-
-
Aboagye, E.O.1
Bhujwalla, Z.M.2
-
71
-
-
0345600050
-
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy
-
P.J. Bolan, S. Meisamy, E.H. Baker, J. Lin, T. Emory, and M. Nelson In vivo quantification of choline compounds in the breast with 1H MR spectroscopy Magn Reson Med 50 6 2003 1134 1143
-
(2003)
Magn Reson Med
, vol.50
, Issue.6
, pp. 1134-1143
-
-
Bolan, P.J.1
Meisamy, S.2
Baker, E.H.3
Lin, J.4
Emory, T.5
Nelson, M.6
-
72
-
-
0344438129
-
Evaluation of cancer therapy using diffusion magnetic resonance imaging
-
B.D. Ross, B.A. Moffat, T.S. Lawrence, S.K. Mukherji, S.S. Gebarski, and D.J. Quint Evaluation of cancer therapy using diffusion magnetic resonance imaging Mol Cancer Ther 2 6 2003 581 587
-
(2003)
Mol Cancer Ther
, vol.2
, Issue.6
, pp. 581-587
-
-
Ross, B.D.1
Moffat, B.A.2
Lawrence, T.S.3
Mukherji, S.K.4
Gebarski, S.S.5
Quint, D.J.6
-
73
-
-
0034694661
-
Diffusion magnetic resonance imaging: A surrogate marker of therapeutic efficacy in brain tumors
-
T.L. Chenevert, L.D. Stegman, J.M. Taylor, P.L. Robertson, H.S. Greenberg, and A. Rehemtulla Diffusion magnetic resonance imaging: a surrogate marker of therapeutic efficacy in brain tumors J Natl Cancer Inst 92 24 2000 2029 2036
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.24
, pp. 2029-2036
-
-
Chenevert, T.L.1
Stegman, L.D.2
Taylor, J.M.3
Robertson, P.L.4
Greenberg, H.S.5
Rehemtulla, A.6
-
74
-
-
0034652156
-
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
-
A.M. Chinnaiyan, U. Prasad, S. Shankar, D.A. Hamstra, M. Shanaiah, and T.L. Chenevert Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci U S A 97 4 2000 1754 1759
-
(2000)
Proc Natl Acad Sci U S a
, vol.97
, Issue.4
, pp. 1754-1759
-
-
Chinnaiyan, A.M.1
Prasad, U.2
Shankar, S.3
Hamstra, D.A.4
Shanaiah, M.5
Chenevert, T.L.6
-
75
-
-
0036794291
-
Nuclear medicine applications in molecular imaging
-
F.G. Blankenberg, and H.W. Strauss Nuclear medicine applications in molecular imaging J Magn Reson Imaging 16 2002 352 361
-
(2002)
J Magn Reson Imaging
, vol.16
, pp. 352-361
-
-
Blankenberg, F.G.1
Strauss, H.W.2
-
76
-
-
0031707409
-
Carbon-11-thymidine and FDG to measure therapy response
-
A.F. Shields, D.W. Mankoff, J.M. Link, M.M. Graham, J.F. Eary, and S.M. Kozawa Carbon-11-thymidine and FDG to measure therapy response J Nucl Med 39 10 1998 1757 1762
-
(1998)
J Nucl Med
, vol.39
, Issue.10
, pp. 1757-1762
-
-
Shields, A.F.1
Mankoff, D.W.2
Link, J.M.3
Graham, M.M.4
Eary, J.F.5
Kozawa, S.M.6
-
77
-
-
0033995078
-
Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole
-
J.S. Rasey, J.J. Casciari, P.D. Hofstrand, M. Muzi, M.M. Graham, and L.K. Chin Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole Radiat Res 153 2000 84 92
-
(2000)
Radiat Res
, vol.153
, pp. 84-92
-
-
Rasey, J.S.1
Casciari, J.J.2
Hofstrand, P.D.3
Muzi, M.4
Graham, M.M.5
Chin, L.K.6
-
78
-
-
0032527120
-
18F-labeled fluorouracil positron emission tomography and the prognosis of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil
-
M. Moehler, A. Dimitrakopoulou-Strauss, F. Gutzler, U. Raeth, L.G. Strauss, and W. Stremmel 18F-labeled fluorouracil positron emission tomography and the prognosis of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil Cancer 83 1998 245 253
-
(1998)
Cancer
, vol.83
, pp. 245-253
-
-
Moehler, M.1
Dimitrakopoulou-Strauss, A.2
Gutzler, F.3
Raeth, U.4
Strauss, L.G.5
Stremmel, W.6
-
79
-
-
0037108692
-
The development of [(124)I]iodinated-VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography
-
D.R. Collingridge, V.A. Carroll, M. Glaser, E.O. Aboagye, S. Osman, and O.C. Hutchinson The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography Cancer Res 62 20 2002 5912 5919
-
(2002)
Cancer Res
, vol.62
, Issue.20
, pp. 5912-5919
-
-
Collingridge, D.R.1
Carroll, V.A.2
Glaser, M.3
Aboagye, E.O.4
Osman, S.5
Hutchinson, O.C.6
-
80
-
-
0032890674
-
Breast cancer imaging with radiolabeled antibodies
-
D.M. Goldenberg, and H.A. Nabi Breast cancer imaging with radiolabeled antibodies Semin Nucl Med 29 1 1999 41 48
-
(1999)
Semin Nucl Med
, vol.29
, Issue.1
, pp. 41-48
-
-
Goldenberg, D.M.1
Nabi, H.A.2
-
81
-
-
0036337131
-
Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology
-
G.M. Lanza, D.R. Abendschein, X. Yu, P.M. Winter, K.K. Karukstis, and M.J. Scott Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology Acad Radiol 9 Suppl 2 2002 S330 S331
-
(2002)
Acad Radiol
, vol.9
, Issue.2
-
-
Lanza, G.M.1
Abendschein, D.R.2
Yu, X.3
Winter, P.M.4
Karukstis, K.K.5
Scott, M.J.6
-
82
-
-
0031862889
-
Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging
-
D.A. Sipkins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C. Li Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 1998 623 626
-
(1998)
Nat Med
, vol.4
, pp. 623-626
-
-
Sipkins, D.A.1
Cheresh, D.A.2
Kazemi, M.R.3
Nevin, L.M.4
Bednarski, M.D.5
Li, K.C.6
-
83
-
-
0034924538
-
In vivo imaging of gene expression: MR and optical technologies
-
C. Bremmer, and R. Weissleder In vivo imaging of gene expression: MR and optical technologies Acad Radiol 8 2001 15 23
-
(2001)
Acad Radiol
, vol.8
, pp. 15-23
-
-
Bremmer, C.1
Weissleder, R.2
-
84
-
-
0042809568
-
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alphavβ3
-
D.B. Ellegala, H. Leong-Poi, J.E. Carpenter, A.L. Klibanov, S. Kaul, and M.E. Shaffrey Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alphaβ3 Circulation 108 2003 336 341
-
(2003)
Circulation
, vol.108
, pp. 336-341
-
-
Ellegala, D.B.1
Leong-Poi, H.2
Carpenter, J.E.3
Klibanov, A.L.4
Kaul, S.5
Shaffrey, M.E.6
-
85
-
-
0032470386
-
Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
-
E.C. Unger, T.P. McCreery, R.H. Sweitzer, V.E. Caldwell, and Y. Wu Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent Invest Radiol 33 1998 886 892
-
(1998)
Invest Radiol
, vol.33
, pp. 886-892
-
-
Unger, E.C.1
McCreery, T.P.2
Sweitzer, R.H.3
Caldwell, V.E.4
Wu, Y.5
-
86
-
-
0032697682
-
Near-infrared optical imaging of protease activity for tumor detection
-
U. Mahmood, C.H. Tung, A. Bogdanov Jr, and R. Weissleder Near-infrared optical imaging of protease activity for tumor detection Radiology 213 1999 866 870
-
(1999)
Radiology
, vol.213
, pp. 866-870
-
-
Mahmood, U.1
Tung, C.H.2
Bogdanov Jr., A.3
Weissleder, R.4
-
87
-
-
0034646351
-
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
-
V. Ntziachristos, A.G. Yodh, M. Schnall, and B. Chance Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement Proc Natl Acad Sci U S A 97 2000 2767 2772
-
(2000)
Proc Natl Acad Sci U S a
, vol.97
, pp. 2767-2772
-
-
Ntziachristos, V.1
Yodh, A.G.2
Schnall, M.3
Chance, B.4
-
88
-
-
23044530493
-
The myth of mechanism
-
T.V. Rajan The myth of mechanism Scientist 15 13 2001 6
-
(2001)
Scientist
, vol.15
, Issue.13
, pp. 6
-
-
Rajan, T.V.1
-
89
-
-
0041885413
-
Functional imaging in phase I studies: Decorations or decision making?
-
J.M. Collins Functional imaging in phase I studies: decorations or decision making? J Clin Oncol 21 15 2003 2807 2809
-
(2003)
J Clin Oncol
, vol.21
, Issue.15
, pp. 2807-2809
-
-
Collins, J.M.1
|